Nutrien (NYSE:NTR) Given New $60.00 Price Target at Scotiabank

Nutrien (NYSE:NTRFree Report) had its target price upped by Scotiabank from $59.00 to $60.00 in a research note released on Monday morning,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock.

Several other brokerages also recently commented on NTR. Raymond James raised Nutrien from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $58.00 to $60.00 in a research note on Tuesday, December 3rd. CIBC reissued an “outperformer” rating and set a $55.00 price target (down from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Barclays reaffirmed an “equal weight” rating and issued a $56.00 price objective (up from $55.00) on shares of Nutrien in a research report on Tuesday, January 21st. Piper Sandler lifted their target price on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Finally, Oppenheimer assumed coverage on Nutrien in a research note on Thursday, December 12th. They issued an “outperform” rating and a $60.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $59.00.

View Our Latest Stock Report on NTR

Nutrien Stock Performance

Shares of NTR opened at $51.95 on Monday. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm’s fifty day simple moving average is $48.73 and its two-hundred day simple moving average is $48.09. Nutrien has a 12 month low of $43.69 and a 12 month high of $60.87. The stock has a market capitalization of $25.51 billion, a P/E ratio of 34.87, a price-to-earnings-growth ratio of 1.13 and a beta of 0.81.

Hedge Funds Weigh In On Nutrien

A number of large investors have recently made changes to their positions in the stock. AQR Capital Management LLC boosted its stake in Nutrien by 28.4% in the 2nd quarter. AQR Capital Management LLC now owns 5,348 shares of the company’s stock worth $272,000 after purchasing an additional 1,184 shares during the period. CWM LLC grew its position in shares of Nutrien by 30.6% during the 3rd quarter. CWM LLC now owns 7,738 shares of the company’s stock valued at $372,000 after purchasing an additional 1,815 shares in the last quarter. Viking Fund Management LLC bought a new position in shares of Nutrien in the third quarter worth $96,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH raised its position in shares of Nutrien by 58.1% in the third quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 2,598 shares of the company’s stock worth $125,000 after buying an additional 955 shares in the last quarter. Finally, Creative Planning boosted its position in shares of Nutrien by 1.3% during the 3rd quarter. Creative Planning now owns 36,524 shares of the company’s stock valued at $1,755,000 after acquiring an additional 473 shares during the last quarter. 63.10% of the stock is owned by institutional investors.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Read More

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.